Search

Your search keyword '"Ausems, M.G.E.M. (Margreet)"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Ausems, M.G.E.M. (Margreet)" Remove constraint Author: "Ausems, M.G.E.M. (Margreet)"
40 results on '"Ausems, M.G.E.M. (Margreet)"'

Search Results

1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

2. Long-term morbidity and health after early menopause due to oophorectomy in women at increased risk of ovarian cancer: Protocol for a nationwide cross-sectional study with prospective follow-up (HARMOny Study)

3. Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making

4. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance

5. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

6. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

7. Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer

8. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

9. ‘We don’t know for sure’: discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations

10. Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

11. Online decision support for persons having a genetic predisposition to cancer and their partners during reproductive decision-making

12. The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study

13. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility

14. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

15. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance

16. MEN1-dependent breast cancer: Indication for early screening? Results from the Dutch MEN1 study group

17. Performance of BRCA1/2 mutation prediction models in male breast cancer patients

18. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

19. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: Clinical daily practice reconsidered

20. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

21. Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

22. Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

23. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

24. Repeated nipple fluid aspiration

25. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

26. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

27. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study

28. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

29. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

30. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

31. Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): A multicentre randomized controlled trial

32. Breast cancer risk and 6q22.33: Combined results from breast cancer association consortium and consortium of investigators on modifiers of brca1/2

33. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

34. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

35. Exploring the link between MORF4L1 and risk of breast cancer

36. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

37. Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits

38. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history

39. The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype

40. Attitude towards pre-implantation genetic diagnosis for hereditary cancer

Catalog

Books, media, physical & digital resources